LEVOSIMENDAN FOR INTENSIVE THERAPY OF HEART FAILURE IN HEART VALVE PROSTHETICS

The article describes perioperative periods of two patients who underwent surgical repair of acquired heart valve disease with artificial circulatory support. In both cases, there was decompensation of chronic heart failure, with levosimendan (Symdax, Orion Pharma, Finland) being used for its treatm...

Full description

Bibliographic Details
Main Authors: O. N. Ulitkina, Zh. S. Filippovskaya, A. A. Tereshina, O. A. Grebenchikov, R. A. Cherpakov, V. E. Babokin, A. M. Ovezov, V. V. Likhvantsev
Format: Article
Language:Russian
Published: MONIKI 2016-02-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
Online Access:https://www.almclinmed.ru/jour/article/view/279